The University of Tokyo Edge Capital

Eureka Robotics specializes in developing robotic technology that offers high accuracy and agility. With offices in Singapore, France, and Vietnam, it serves various industries such as healthcare, telecom, automotive, photonics, electronics, optics, and aerospace by automating precision handling, assembly, inspection tasks. Its software and systems enable clients to enhance productivity, reduce costs, and improve safety.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

United Immunity, Co., Ltd. is a research and development company based in Tsu, Japan, specializing in the manufacture and sales of pharmaceuticals with a primary focus on cancer immunotherapy. Founded in November 2017, the company develops innovative nanoparticles and lipid nanoparticles aimed at targeting myeloid cells to treat cancer and infectious diseases. United Immunity's technology enables the delivery of various therapeutic agents directly to macrophages and dendritic cells, facilitating the development of treatments for a range of conditions, including cancer, autoimmune diseases, fibrosis, and infectious diseases.

Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.

HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

Eureka Robotics specializes in developing robotic technology that offers high accuracy and agility. With offices in Singapore, France, and Vietnam, it serves various industries such as healthcare, telecom, automotive, photonics, electronics, optics, and aerospace by automating precision handling, assembly, inspection tasks. Its software and systems enable clients to enhance productivity, reduce costs, and improve safety.

Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

DATAFLUCT is a data science company in Japan that provides data management and machine learning services to address corporate and social issues. Its platform handles the collection, storage, analysis, and utilization of diverse data, enabling businesses to predict outcomes and create value from big data. The company focuses on multimodal data integration and rapid, high-precision data utilization through sustainable algorithms that balance environmental, social, customer, and economic value. It also offers tools such as a satellite imagery search service that broadens access to geospatial data, supporting data-driven decision making.

HashPort, founded in 2018, supports new web3 businesses by offering development and financing solutions, including Initial Exchange Offerings (IEOs). The company specializes in creating crypto-asset products such as digital wallets and provides consulting services aimed at digitalizing assets. HashPort also focuses on wallet systems and non-fungible token platforms, helping cryptocurrency exchange firms implement blockchain technologies. Its subsidiary, HashPalette, established in 2020, made notable strides by conducting Japan's first approved IEO, developing a blockchain tailored for NFTs, and operating one of the country's largest NFT marketplaces. In April 2023, HashPort secured over 1.2 billion yen in a Series C funding round involving six underwriters.

Metcela is a clinical-stage biotechnology company based in Kawasaki, Japan, developing fibroblast-based therapies for heart disease. Its approach uses VCAM-1–positive cardiac fibroblasts derived from a patient’s own heart to repair damaged tissue and reestablish a supportive microenvironment, rather than replacing cells. The lead program, MTC001, aims to restore heart function by promoting natural healing in preclinical studies. Metcela was founded in 2016.

Capex Co., Ltd. is a Tokyo-based company that specializes in the planning and development of PATONA, an artificial intelligence application designed to serve as a life partner. Founded in 2019, Capex focuses on creating an engaging user experience through an AI bot that employs natural language processing, allowing users to communicate and interact meaningfully. The application aims to enhance human connections and address feelings of loneliness by providing a virtual companion that reflects the user's personal life and interactions. Through its innovative approach, Capex seeks to promote the harmonious coexistence of technology and human experiences.

Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

TXP Medical Inc., established in 2017 and headquartered in Bunkyo, Japan, specializes in developing and selling patient information recording and management systems. The company's primary product is NEXTStage ER, a platform supporting both medical record input and research, along with NSER mobile for voice-command and image OCR-based patient data entry. Additionally, TXP Medical offers Self Assessment System enabling patients to input their own data. These solutions aim to connect medical information across different fronts, fostering data-driven decision-making and improving overall healthcare outcomes.

Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

Algal Bio Co., Ltd., established in 2018, is a Japanese company specializing in the research, development, production, and sale of algae and its components. Headquartered in Kashiwa, Japan, the company focuses on extracting rare fatty acids and carotenoids from algae, operating within food processing, importing, exporting, and distributing algae-related ingredients. Algal Bio was founded upon two decades of research from the University of Tokyo, aiming to harness microalgae's potential as functional food ingredients.

Retrieva is a Tokyo-based developer of AI software for call centers, combining natural language processing and machine learning to analyze inquiries and assist with responses for enterprise clients. The company focuses on research, development, and ongoing support of ML-driven software, and its product family includes Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, an analysis software solution. Founded in 2016, Retrieva serves organizations seeking scalable, AI-powered customer service solutions.

Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.

OriCiro Genomics is a Japanese biotechnology company founded in 2018, based in Minato-ku. It specializes in developing innovative genome technologies, particularly focusing on cell-free synthesis and amplification of large DNA molecules for synthetic biology applications. The company's core technologies include DNA assembly and circular DNA amplification, which enable the construction of large circular DNA molecules without traditional biological cloning methods. OriCiro Genomics serves life science research and development companies, offering solutions that facilitate advancements in gene therapy, pharmaceuticals, diagnostics, food, and agriculture by leveraging synthetic biology.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

Estie, Inc. is a real estate technology company based in Tokyo, Japan, founded in 2018. It specializes in digital transformation within the commercial real estate sector, offering a software as a service (SaaS) platform that enhances the flow of information and transactions. Estie provides a range of services, including market research and algorithms for rent estimation, which help clients make informed, data-driven decisions. By leveraging innovative software solutions, Estie aims to unlock the value of the commercial real estate industry, facilitating a more efficient and effective decision-making process for its users.

BionicM is a Tokyo‑based company that develops robotic prostheses for lower‑limb amputees. Its products include powered knee joints and ankle‑foot devices that mimic natural muscle function, allowing users to stand, walk, and climb stairs with reduced effort. The company’s technology was first researched in 2015 at the University of Tokyo’s Information Systems Engineering Laboratory and received support from the Japan Science and Technology Agency in 2016. BionicM was formally established in 2018 and continues to advance high‑performance prosthetic solutions that enhance mobility for people with disabilities.

PharmaBio Corporation is a healthcare company specializing in the contract development and manufacturing of cellular and tissue-based products. Founded in 1978 and headquartered in Nagoya, Japan, with an administrative branch in Tokyo, the company focuses on the development of cell-based investigational new drugs and offers a range of services including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a GMP-compliant facility for the storage of cell-based drugs and test specimens, ensuring high standards of safety and quality. Additionally, the company provides strategic development consultation to support regulatory processes in cell and tissue-based medicine, aiming to enhance medical and social progress through its innovative products and services.

Socium Inc. is a Japan-based company specializing in AI-powered drug discovery and development. It focuses on creating first-in-class small molecules and has a diverse development portfolio that targets over 23 diseases, including oncology and rare diseases. Utilizing a systems biology approach, Socium leverages advanced algorithms and machine learning to streamline the traditional drug discovery process by employing an in-silico system. This innovative method allows the company to identify drug discovery targets more quickly, often within a few months. Additionally, Socium analyzes a wide array of omics data to profile entire diseases rather than concentrating solely on related compounds, which enhances the efficacy and breadth of its research efforts. By integrating drug repositioning strategies, Socium also seeks to uncover new therapeutic uses for existing commercial drugs, thereby contributing to advancements in healthcare.

Founded in 2018, Neural Pocket specializes in developing proprietary AI technologies for image and video detection, classification, and behavior analysis. The company offers services for smart city development, facility management, digital signage, and fashion trend analysis.

Founded in Tokyo, Japan in 2015, AI Inside specializes in software development and artificial intelligence. It offers DX Suite, an AI-powered Optical Character Recognition (OCR) platform, transforming information into digital data to enhance productivity.

Founded in Tokyo in 2014, Startbahn operates a blockchain-based platform focused on enhancing the art industry globally. It specializes in issuing blockchain certificates for artwork authentication and traceability via its Startbahn Cert service. Additionally, it develops Startrail, a blockchain infrastructure supporting Startbahn Cert, and collaborates with other companies on joint projects.

Fressets, Inc., established in 2017 and based in Tokyo, Japan, specializes in developing cryptocurrency wallet systems for virtual currency exchanges. The company's core business is an enterprise wallet management (EWM) system, primarily serving cryptocurrency exchanges and custodians. This system employs multisignature addresses and secure hardware for key storage, ensuring robust security against hacker threats. It combines the advantages of secure cold wallets and convenient hot wallets, providing clients with a balance of security and scalability for smooth cryptocurrency transactions.

Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.

Algal Bio Co., Ltd., established in 2018, is a Japanese company specializing in the research, development, production, and sale of algae and its components. Headquartered in Kashiwa, Japan, the company focuses on extracting rare fatty acids and carotenoids from algae, operating within food processing, importing, exporting, and distributing algae-related ingredients. Algal Bio was founded upon two decades of research from the University of Tokyo, aiming to harness microalgae's potential as functional food ingredients.

Socium Inc. is a Japan-based company specializing in AI-powered drug discovery and development. It focuses on creating first-in-class small molecules and has a diverse development portfolio that targets over 23 diseases, including oncology and rare diseases. Utilizing a systems biology approach, Socium leverages advanced algorithms and machine learning to streamline the traditional drug discovery process by employing an in-silico system. This innovative method allows the company to identify drug discovery targets more quickly, often within a few months. Additionally, Socium analyzes a wide array of omics data to profile entire diseases rather than concentrating solely on related compounds, which enhances the efficacy and breadth of its research efforts. By integrating drug repositioning strategies, Socium also seeks to uncover new therapeutic uses for existing commercial drugs, thereby contributing to advancements in healthcare.

Epigeneron, Inc. is a biotechnology company based in Chuo, Japan, founded in 2015. The company focuses on the research, development, manufacturing, and marketing of pharmaceutical drugs, particularly in the areas of cancer, dementia, metabolic disorders, and infectious diseases. Epigeneron specializes in drug discovery, offering services that include the development of epigenetic and antimicrobial drugs. The company employs advanced techniques such as chromatin immunoprecipitation to isolate specific genomic regions, thereby facilitating the identification of molecules that interact with these regions. This innovative approach enables the development of gene therapies aimed at treating severe immune diseases and other serious health conditions, including fibrosis and disorders of the central nervous system. Additionally, Epigeneron is involved in the manufacture and sale of research reagents, diagnostic agents, and research equipment, alongside supporting drug discovery efforts through information services and intellectual property transfer.

Founded in 2018, Neural Pocket specializes in developing proprietary AI technologies for image and video detection, classification, and behavior analysis. The company offers services for smart city development, facility management, digital signage, and fashion trend analysis.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

PharmaBio Corporation is a healthcare company specializing in the contract development and manufacturing of cellular and tissue-based products. Founded in 1978 and headquartered in Nagoya, Japan, with an administrative branch in Tokyo, the company focuses on the development of cell-based investigational new drugs and offers a range of services including microbial safety testing, specimen storage, and genetic testing for pathogenic viruses. PharmaBio operates a GMP-compliant facility for the storage of cell-based drugs and test specimens, ensuring high standards of safety and quality. Additionally, the company provides strategic development consultation to support regulatory processes in cell and tissue-based medicine, aiming to enhance medical and social progress through its innovative products and services.

Provigate is a company based in Japan that specializes in bio-transistor sensor technologies. It develops advanced diagnostic instruments capable of measuring blood sugar levels, utilizing perception-broadening sensors. These innovative technologies allow individuals, particularly those with diabetes, to monitor their glucose levels regularly, facilitating better management of their health and lifestyle habits. By providing accurate and dynamic measurements, Provigate aims to empower users to make informed decisions about their health.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

Founded in 2014, Aidemy offers an online platform for individuals to learn artificial intelligence programming and for businesses to leverage AI technology using their own data. Its services include practical blockchain applications, supporting DX human resource development, problem selection, proof-of-concept development, and operation.

NS Materials Corp. is a manufacturer and distributor of semiconductor-related equipment and systems, located in Chikushino-shi, Japan. The company focuses on the development of micro-space chemical technologies, particularly in the area of nano-phosphor for LED lighting. Additionally, NS Materials specializes in chemical synthesis technologies that aim to advance nanotechnology and biotechnology. By creating innovative tools and products, the company contributes to the promotion of a low-carbon society and seeks to significantly impact people's lives.

FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

Retrieva is a Tokyo-based developer of AI software for call centers, combining natural language processing and machine learning to analyze inquiries and assist with responses for enterprise clients. The company focuses on research, development, and ongoing support of ML-driven software, and its product family includes Talk Coordinator, an operator software solution; Voice Visualizer, an administrator software solution; and VoC Analyzer, an analysis software solution. Founded in 2016, Retrieva serves organizations seeking scalable, AI-powered customer service solutions.

Routrek Networks, Inc. is a technology company based in Kawasaki, Japan, specializing in hardware and software solutions for network systems. Founded in 2005, the company advances the Internet of Things (IoT) to support sustainable farming practices, offering innovative solutions to address food production challenges. Routrek Networks provides an automatic irrigation system that utilizes sensors and agricultural equipment to optimize irrigation based on soil moisture levels, thereby enhancing crop yield for small to mid-sized farmers. Additionally, the company offers RouteMagic, a comprehensive network monitoring system that includes RouteMagic Server and RouteMagic Console Manager, enabling effective remote management and control of agricultural operations.

Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

SEAOS, Inc. is a Tokyo-based company founded in 2000 that specializes in developing software applications for the logistics industry. In addition to software development, SEAOS provides business consulting services focused on logistics strategy and product licensing. The company is also involved in the development of robotics solutions, enhancing operational efficiency within the logistics sector. With its comprehensive approach to logistics and technology, SEAOS aims to support businesses in navigating the complexities of modern supply chain management.

ReasonWhy Inc., founded on July 7, 2011, is a Japan-based company that specializes in healthcare IT services. The company offers a suite of innovative solutions designed to enhance communication and information access within the medical field. Its key services include Whytlink, a social network tailored for medical professionals; Findme, an online platform that connects patients with doctors for second opinions; WhytPlot, a big-data analysis tool aimed at pharmaceutical manufacturers; and yourHospital, a search engine that helps users find specialist hospitals. Through these services, ReasonWhy aims to improve healthcare delivery and facilitate better patient outcomes.

Autonomous Control Systems Laboratory Ltd. is an industrial drone manufacturer and solution provider based in Tokyo, Japan, founded in 1998 from the laboratory of Professor Kenzo Nonami at Chiba University. The company specializes in the development, production, and servicing of fully automated drones designed for a wide range of applications, including delivery, inspection, disaster relief, logistics, aerial photography, and surveying. With a focus on research and development, ACSL utilizes proprietary technologies developed in Japan to contribute to the advancement of industrial drone solutions. The company aims to be at the forefront of the new industrial revolution in the global skies, providing innovative solutions for various industrial needs.

Liquid, Inc. is a Tokyo-based company founded in 2013 that specializes in the manufacture and development of biometric identity verification and payment devices. The company focuses on fingerprint sensing technology, which enables users to register payment methods, such as point cards and credit cards, using their fingerprint information. This innovative approach allows customers to complete transactions simply by using their fingerprints. Liquid also develops related software that employs advanced authentication algorithms and image analysis technology to enhance security and convenience in payment processes.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.

FLOSFIA INC. is a Tokyo-based company that focuses on the development of corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, the company emerged as a spin-off from research conducted at Kyoto University. FLOSFIA specializes in film-formation using mist chemical vapor deposition (CVD) techniques, leveraging the unique physical properties of gallium oxide (Ga2O3) to create high breakdown voltage and high efficiency power devices. The firm is dedicated to advancing low-loss power device technology, contributing to the evolution of semiconductor applications.

Crewt Medical Systems, established in Tokyo, Japan in 2013, specializes in manufacturing innovative medical devices. The company's flagship product is the world's first head-mounted perimeter, designed to meet clinical needs and compatible with standard automated perimeters. Crewt's mission is to create new value in healthcare by integrating advanced technologies, focusing on human-centric solutions that enhance visual quality.

Seven Dreamers Laboratories, Inc. is a Tokyo-based company that specializes in designing and manufacturing innovative medical devices and personal-use technology. Founded in 2011, the company is known for its commitment to developing unique, world-first products. One of its notable creations is the Laundroid, a laundry-folding robot that employs image-recognition algorithms and artificial intelligence to identify various types of clothing, fold them accordingly, and sort them by item or family member. This technology aims to significantly enhance everyday life by automating household chores, thereby allowing users to spend their time on more meaningful activities.

Vegetalia, Inc. is an agricultural technology company based in Tokyo, Japan, established in 2010. The company specializes in developing and marketing measurement monitoring systems and cloud-based application solutions tailored for the agricultural industry. Its flagship products include FieldServer, which integrates field sensors with web and mobile applications for outdoor monitoring, and PaddyWatch, a water management system specifically designed for rice cultivation. Additionally, Vegetalia offers agri-note, a cloud service that supports field management and work analysis. The company employs IoT technology and data analytics to optimize farming practices, enabling agricultural professionals and farmers to efficiently monitor and manage their fields. Vegetalia also operates plant clinics, further enhancing its commitment to sustainable agricultural practices.

Goryo Chemical, Inc. is a Japanese company specializing in the development of fluorescent probes and functional dyes for applications in chemical biology and diagnostics. Founded in 2010 and headquartered in Sapporo, with an additional office in Tokyo, the company offers a range of products including AcidiFluor, CalFluor, GlycoFluor, and MetalloFluor, among others. These fluorescent probes are designed for cellular analysis, assay, and imaging, enabling selective staining of acidic organelles such as lysosomes and late endosomes. Goryo Chemical also provides bioluminescent probes, labeling services, and custom synthesis, catering to various needs in molecularly-targeted drug and immunoassay applications. The company serves its customers through a network of distributors both domestically and internationally.

Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.

Quantum Biosystems Inc. is a company focused on the development of quantum bio sequencing technologies. Founded on January 7, 2013, and based in Yodogawa-ku, Japan, the company specializes in innovative single-molecule DNA and RNA sequencing systems. By applying principles of quantum mechanics, Quantum Biosystems aims to enhance the analysis of whole genomes, providing clients with advanced tools for gathering genetic data. Their systems have broad applicability, enabling researchers to unlock genetically modified codes and promote advancements in various fields of study. Through its pioneering technology, Quantum Biosystems is positioned to make significant contributions to the field of genomics.

Molcure is a biopharmaceutical company focused on antibody and peptide drug discovery. The company combines expertise in next-generation sequencing, bioinformatics, and antibody biology with an automated discovery system to identify high-quality antibody candidates and peptide therapeutics, aiming to shorten research and development timelines for pharmaceutical partners. Its Abtracer platform provides antibody sequence screening to detect functional candidates, and its SmartLabModule integrates IoT-enabled laboratory workflows to support efficient science. Through in-house capabilities and partnerships, Molcure seeks to advance therapeutic antibodies and related therapies, focusing on improving patient outcomes. Founded in 2013 and based in Tokyo, Molcure positions itself as a partner for therapeutic antibody discovery, offering automation and knowledge to accelerate discovery processes.

Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.

Nabiq Inc. offers outsourcing services tailored for wireless broadband environments, focusing on the integration of existing fixed broadband lines with Wi-Fi technology. The company specializes in designing radio zones, installing, and operating wireless broadband solutions for various local settings, including hotels, hospitals, condominiums, and schools. Its cloud-based platform facilitates secure network connectivity for smartphones and tablets, creating a seamless access environment. Founded in 2013 and headquartered in Chiyoda, Japan, Nabiq operates as a subsidiary of JTOWER Inc.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.

Quantum Biosystems Inc. is a company focused on the development of quantum bio sequencing technologies. Founded on January 7, 2013, and based in Yodogawa-ku, Japan, the company specializes in innovative single-molecule DNA and RNA sequencing systems. By applying principles of quantum mechanics, Quantum Biosystems aims to enhance the analysis of whole genomes, providing clients with advanced tools for gathering genetic data. Their systems have broad applicability, enabling researchers to unlock genetically modified codes and promote advancements in various fields of study. Through its pioneering technology, Quantum Biosystems is positioned to make significant contributions to the field of genomics.

GlyTech specializes in the production of human-type N-glycans and chemical glycosylation technologies. It offers custom synthesis services, contract manufacturing, and licenses its products for use in biopharmaceuticals and oligonucleotide therapeutics.

Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.

Prometech Software, Inc. is a technology company based in Tokyo, Japan, founded in 2004. It specializes in the development of virtual reality technologies, focusing on interactive experiences through advanced physics simulation software and computer graphics. The company offers innovative computer-aided engineering (CAE) solutions, particularly in fluid simulation using the Particle Method, which aids in product development by providing detailed fluid analysis and facilitating the construction of 3D environments. Prometech Software is dedicated to enhancing user interactivity within virtual realities, making significant contributions to the fields of simulation and virtual technology.

Mujin is a Tokyo-based company that develops intelligent robot controllers and factory automation solutions for industrial robotics. It provides a universal controller platform that integrates motion planning with machine vision and programmable logic controllers to automate heavy and repetitive tasks in logistics and manufacturing. The company offers products such as Mujin Controller Sim, a platform for programming industrial robots; Mujin Scanner, which creates 3D models of objects or environments; Pick Worker, a bin-picking system with real-time motion planning; and Laser Worker, a laser cutting system powered by motion planning. In addition to hardware and software tools, Mujin supplies services in robot and controller design, teaching and simulation, legacy-system support, and system integration. Its technology focuses on optimizing offline motions and enabling real-time operation across complex workflows, reducing dependence on manual handling in dynamic industrial settings.

Phyzios is a software company based at the University of Tokyo, established in January 2009. It specializes in developing gaming applications that utilize advanced physical simulation technology, allowing materials to be treated as particles with varying properties. This innovative approach enables developers to create interactive experiences for touch panel devices. Phyzios has achieved notable success in the mobile application market, with several of its iPhone and iPod touch applications ranking among the top 10 in their respective categories on the Japanese App Store. Notably, its application PHYZIOS Sculptor ranked as the second most popular free application in Japan and first in Italy. As a spin-off from Prometech Software, Inc., Phyzios continues to focus on enhancing user engagement through its unique simulation capabilities.

RaQualia Pharma Inc. is a pharmaceutical research and development company based in Nagoya, Japan, focusing on innovative treatments for various medical conditions. The company offers products such as Tegoprazan for gastroesophageal reflux diseases and Galliprant and ENTYCE for managing pain and anorexia in pets, respectively. RaQualia is also developing several compounds, including a Cyclooxygenase-2 Inhibitor in Phase I trials for pain relief, as well as Grapiprant, which is being tested for colorectal cancer and non-small cell lung cancer. Additionally, the company is advancing multiple candidates for gastrointestinal disorders, pain management, and psychiatric conditions, such as a 5-HT4 Partial Agonist and a P2X7 Receptor Antagonist. RaQualia also licenses and sells intellectual property related to its pharmaceutical compounds and maintains collaborative agreements with various organizations, enhancing its development capabilities. Founded in 2008, RaQualia Pharma is committed to advancing healthcare through its innovative research initiatives.

PopIn Inc. is a Tokyo-based company founded in July 2008 by Cheng Tao, specializing in online advertising services. The company focuses on developing tools that allow users to measure the effectiveness of advertisements by comparing the estimated reading time of an ad with the time spent by users on a website. PopIn's mission is to enhance the browsing experience for internet users by integrating information in a way that effectively addresses their needs. As of May 2015, PopIn operates as a subsidiary of Baidu Japan, Inc.

Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.

NanoCarrier Co., Ltd. is a pharmaceutical company based in Kashiwa, Japan, specializing in the research, development, production, and sale of pharmaceutical products utilizing micellar nanoparticle technology. Founded in 1996, the company focuses primarily on cancer treatments, boasting a diverse product pipeline that includes NC-6004, a Cisplatin micelle targeting various cancers such as pancreatic and non-small cell lung cancer; VB-111, an Adeno 5 vector designed for rGBM and ovarian cancer; and NC-6300, which utilizes Epirubicin micelle for soft tissue sarcoma. Additional offerings include NC-4016, a Dach-platinum micelle for solid tumors, and NK105, a Paclitaxel micelle aimed at breast and gastric cancers. With a commitment to advancing cancer therapeutics, NanoCarrier continues to innovate in the pharmaceutical industry.

Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.

Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.